GSK's MRNA Flu Vaccine Advances to Late-Stage Clinical Development After Positive Trial Results

GSK的MRNA流感疫苗在積極的試驗結果後進入晚期臨床開發階段

WSJ · 09/12 02:35

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.